415 related articles for article (PubMed ID: 15285175)
1. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
2. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
3. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.
Christgau S; Bitsch-Jensen O; Hanover Bjarnason N; Gamwell Henriksen E; Qvist P; Alexandersen P; Bang Henriksen D
Bone; 2000 May; 26(5):505-11. PubMed ID: 10773591
[TBL] [Abstract][Full Text] [Related]
4. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
[TBL] [Abstract][Full Text] [Related]
5. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
7. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
Asaba Y; Hiramatsu K; Matsui Y; Harada A; Nimura Y; Katagiri N; Kobayashi T; Takewaka T; Ito M; Niida S; Ikeda K
Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925
[TBL] [Abstract][Full Text] [Related]
8. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Echevarría M; Ros I; Ballesta AM; Muñoz-Gómez J
J Bone Miner Metab; 2002; 20(2):116-20. PubMed ID: 11862534
[TBL] [Abstract][Full Text] [Related]
9. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
[TBL] [Abstract][Full Text] [Related]
10. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
12. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD
J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889
[TBL] [Abstract][Full Text] [Related]
13. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis.
Eastell R; Colwell A; Hampton L; Reeve J
J Bone Miner Res; 1997 Jan; 12(1):59-65. PubMed ID: 9240726
[TBL] [Abstract][Full Text] [Related]
15. Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years.
Qvist P; Munk M; Hoyle N; Christiansen C
Clin Chim Acta; 2004 Dec; 350(1-2):167-73. PubMed ID: 15530474
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy.
Tobias JH; Clarke S; Mitchell K; Robins S; Amer H; Fraser WD
J Clin Endocrinol Metab; 2001 Mar; 86(3):1194-8. PubMed ID: 11238508
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men.
Fall PM; Kennedy D; Smith JA; Seibel MJ; Raisz LG
Osteoporos Int; 2000; 11(6):481-5. PubMed ID: 10982162
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers in menopausal women.
Griesmacher A; Peichl P; Pointinger P; Mateau R; Bröll H; Hartl W; Gruber W
Scand J Clin Lab Invest Suppl; 1997; 227():64-72. PubMed ID: 9127469
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.
Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ
J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
